Objective Amiodarone is frequently associated with thyroid dysfunction. Identifying
predictors for amiodarone‐associated thyroid dysfunction and assessing treatment outcome …

Diagnostic and therapeutic challenges abound in amiodarone-treated patients. Amiodarone
therapy results in perturbations in tests of thyroid function in euthyroid individuals as well as …

Background Amiodarone is associated with a number of significant adverse effects,
including elevated transaminase levels, pulmonary fibrosis, arrhythmia, and thyroid …

Objective Amiodarone is used for the maintenance of sinus rhythm in patients with
arrhythmias, but thyroid dysfunction (amiodarone-induced thyrotoxicosis (AIT) or …

Amiodarone is a highly eVective agent for the prophylaxis and treatment of many cardiac
rhythm disturbances, ranging from paroxysmal atrial fibrillation to life threatening ventricular …

Amiodarone is a class III antiarrhythmic drug containing 37% iodine by weight, with a
structure similar to that of thyroid hormones. Deiodination of amiodarone releases large …

Background: Amiodarone-induced thyrotoxicosis (AIT) is a clinical condition that is
notoriously difficult to manage; the relative risk of adverse cardiovascular events in these …

Objectives: To determine the incidence and predictability of amiodarone-induced
thyrotoxicosis (AIT) and hypothyroidism (AIH) in patients with cardiomyopathy. Patients and …

Amiodarone-induced thyroid dysfunction occurs in 15–20% of amiodarone-treated patients.
Amiodarone-induced hypothyroidism (AIH) does not pose relevant problems, is easily …

Amiodarone-induced thyrotoxicosis (AIT) is a clinical condition fraught with difficulties and
uncertainties both from the diagnostic and therapeutic standpoints (1). Diagnosis and …